Efforts to broaden the commercial appeal of Abbott’s lipid franchise, which also includes Niaspan (extended-release niacin) and Simcor (simvastatin/niacin extended release), hinges on a fixed-dose combination of TriLipix and Crestor, to be called Certriad.
What are the competitive threats coming down the pipeline? Continue Reading at BNET Pharma….
Editor David J Phillips does not hold a financial interest in any stocks mentioned in this article. The 10Q Detective has a Full Disclosure Policy.